Clinical Trials Logo

Keratitis clinical trials

View clinical trials related to Keratitis.

Filter by:

NCT ID: NCT01756456 Completed - Keratitis Clinical Trials

Evaluation of Safety and Efficacy of rhNGF in Patients With Stage 2 and 3 Neurotrophic Keratitis.

REPARO
Start date: January 2013
Phase: Phase 1/Phase 2
Study type: Interventional

This study is aimed at assessing the safety and the efficacy of two dose regimens of recombinant human nerve growth factor (rhNGF) eye drops solution compared to vehicle for inducing a complete healing of stage 2 (persistent epithelial defect) and 3 (corneal ulcer) neurotrophic keratitis

NCT ID: NCT01739673 Completed - Clinical trials for Infectious Keratitis

Ultraviolet-A and Riboflavin Treatment for Infectious Keratitis

Start date: August 2011
Phase: N/A
Study type: Interventional

This study is to evaluate the efficacy of ultraviolet-A (UVA) and riboflavin application (also often referred to as corneal collagen crosslinking) as a method to enhance treatment of infectious keratitis.

NCT ID: NCT01437319 Completed - Clinical trials for Corneal Inflammation

Mucin Balls and Corneal Inflammation Events

Start date: September 2011
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine if the formation of mucin balls is a marker for protection from inflammatory events to the cornea and if mucin balls play a role in protection during extended contact lens wear.

NCT ID: NCT01272271 Completed - Myopia Clinical Trials

Safety of Overnight Corneal Reshaping Lenses

Start date: February 2008
Phase:
Study type: Observational

This retrospective chart review study compares the incidence of corneal inflammation due to infection in children vs. adult patients wearing overnight corneal reshaping lenses.

NCT ID: NCT01268306 Completed - Keratitis Clinical Trials

Study of the Presence and Extent of Corneal Disturbance Associated With B+L Biotrue MPS Used With B+L PureVision Lenses

Start date: October 2010
Phase: Phase 4
Study type: Interventional

Corneal epithelial disruption, commonly termed "corneal staining" has been frequently associated with contact lens wear. Previous research has demonstrated higher levels of observed corneal staining when certain combinations of contact lenses and lens care products are used, particularly under daily wear regimens. B+L lenses made from Balafilcon (PureVision) have been associated with the highest rates of observed staining. Additionally, polyhexamethylene biguanide (PHMB) based lens care products, specifically B+L ReNu MultiPlus have been implicated in higher rates of staining. In general, many lenses constructed from newer, silicone hydrogel (SiHy) materials appear more susceptible to increased rates and amounts of corneal staining. Although the clinical significance of staining is debated, most clinicians agree that less staining is preferable to greater amounts of staining. Advances in understanding as well as the specifics of lens care product formulation ideally will have resulted in design of newer products that minimize corneal staining and maximize product performance. This study will examine rates of corneal staining using B+L's recently introduced lens care product: BioTrue with the B+L PureVision lens which has previously been associated with the highest levels of staining.

NCT ID: NCT01028027 Completed - Blepharitis Clinical Trials

Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis

Start date: October 2009
Phase: Phase 3
Study type: Interventional

This study is to evaluate the safety and efficacy of loteprednol etabonate [LE] and tobramycin ophthalmic suspension versus tobramycin and dexamethasone ophthalmic suspension in the treatment of ocular inflammation associated with blepharokeratoconjunctivitis (BKC).

NCT ID: NCT00949468 Completed - Keratitis Clinical Trials

Microbiological Keratitis in a Countryside City of Brazil

Start date: June 2008
Phase: N/A
Study type: Observational

The purpose of this study is to identify the predisposing factors, epidemiological features and clinical and microbiological diagnosis of infectious keratitis in two public referral centers of ophthalmology in a countryside city of Brazil.

NCT ID: NCT00732446 Completed - Blepharitis Clinical Trials

Safety/Efficacy of Antibiotic Steroid Combination in Treatment of Blepharitis and/or Keratitis and/or Conjunctivitis

BRA-07-02
Start date: August 2008
Phase: Phase 3
Study type: Interventional

Safety and efficacy of antibiotic steroid combination compared with individual administration in the treatment of bacterial ocular inflammation and infection (blepharitis and/or keratitis and/or conjunctivitis).

NCT ID: NCT00707005 Completed - Bacterial Keratitis Clinical Trials

Antibiotic Susceptibility of Conjunctival Bacterial Isolates From Refractive Surgery Patients

Start date: June 2008
Phase: N/A
Study type: Observational

The purpose of this study is to determine the in vitro antibiotic susceptibility patterns of conjunctival bacterial flora isolated preoperatively from patients undergoing refractive surgery.

NCT ID: NCT00557362 Completed - Fungal Keratitis Clinical Trials

Therapeutic Exploratory Study of Comparing Natamycin and Voriconazole to Treat Fungal Corneal Ulcer

MUTT_TE
Start date: November 2007
Phase: Phase 1/Phase 2
Study type: Interventional

We evaluated whether voriconazole is a superior treatment to natamycin for filamentous fungal keratitis in a randomized, masked, controlled trial. This is a therapeutic exploratory study to investigate the safety and feasibility of conducting a larger study and to generate preliminary data.